Exclusive Interviews

Traditional Pharmatechniques have struggled for decades to make inroads into diseases whose roots lie deep in molecular biology. Today’s modern Biopharma has extended that reach into the foundations of cancer, heart disease, genetic disease, and a host of other afflictions. In the coming years, the therapies and cures offered by this extended reach will increasingly

The Need for Regenerative Therapies It is clear that the current healthcare sector needs a shift towards regenerative therapies to help the correction of underlying diseases by utilizing innate healing systems as opposed to therapies based on symptomatic interventions with attendant side effects, comorbidities and excessive costs. By “Harnessing the Power of CellsTM, the US-based

Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of Novartis, its purpose is to discover new ways to improve and extend people’s lives by pioneering novel approaches to provide access to high-quality medicines. Global headquarters are in Holzkirchen, Germany and US headquarters in Princeton, New Jersey. With its experience and